- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
4
Companies available at a discount paying at least a 2% dividend yield.
4 companies
Johnson & Johnson
Market Cap: US$579.3b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$242.59
7D
-2.4%
1Y
44.7%
Merck
Market Cap: US$286.3b
Operates as a healthcare company worldwide.
MRK
US$117.11
7D
-3.5%
1Y
23.0%
Gilead Sciences
Market Cap: US$178.7b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$146.63
7D
-2.3%
1Y
25.1%
Qiagen
Market Cap: US$9.2b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$43.33
7D
-11.3%
1Y
5.8%